Annals of SBV

Register      Login

VOLUME 9 , ISSUE 1 ( January-June, 2020 ) > List of Articles

REVIEW ARTICLE

Hyponatremia: A Clinical and Practical Approach

Varun KM Dhara

Citation Information : Dhara VK. Hyponatremia: A Clinical and Practical Approach. 2020; 9 (1):17-21.

DOI: 10.5005/jp-journals-10085-8113

License: CC BY-NC 4.0

Published Online: 03-08-2020

Copyright Statement:  Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Hyponatremia is a frequent trouble encountered in patients manifesting with unfocused features. The etiology can be multiple, and diagnosis of each cause is demanding. Hyponatremia may be euvolemic, hypovolemic, or hypervolemic. Appropriate analysis of a variety of laboratory investigations helps distinguish the various types of hyponatremia. Management differs with the character of start, whether it is acute or chronic, severity and features.


PDF Share
  1. Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med 2013;126(10 Suppl 1):S1–S42.
  2. Reynolds RM, Seckl JR. Hyponatraemia for the clinical endocrinologist. Clin Endocrinol (Oxf) 2005;63(4):366–374. DOI: 10.1111/j.1365-2265.2005.02318.x.
  3. Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol JASN 1994;4(8):1522–1530.
  4. Upadhyay A, Jaber BL, Madias NE. Epidemiology of hyponatremia. Semin Nephrol 2009;29(3):227–238. DOI: 10.1016/j.semnephrol.2009.03.004.
  5. Burst V. Etiology and epidemiology of hyponatremia. Disord Fluid Electrolyte Metab 2019;52:24–35. DOI: 10.1159/000493234.
  6. Anderson RJ. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 1985;102(2):164. DOI: 10.7326/0003-4819-102-2-164.
  7. Hao J, Li Y, Zhang X, Pang C, Wang Y, Nigwekar SU, et al. The prevalence and mortality of hyponatremia is seriously underestimated in Chinese general medical patients: an observational retrospective study. BMC Nephrol 2017(1):18. DOI: 10.1186/s12882-017-0744-x.
  8. Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med 2010;170(3):294–302. DOI: 10.1001/archinternmed.2009.513.
  9. Hyponatremia - Symptoms and causes. Mayo Clinic.
  10. Pillai BP, Unnikrishnan AG, Pavithran PV. Syndrome of inappropriate antidiuretic hormone secretion: revisiting a classical endocrine disorder. Indian J Endocrinol Metab 2011;15(Suppl 3):S208–S215. DOI: 10.4103/2230-8210.84870.
  11. Sahay M, Sahay R. Hyponatremia: a practical approach. Indian J Endocrinol Metab 2014;18(6):760. DOI: 10.4103/2230-8210.141320.
  12. Anker NB, Cho KC. Hyponatremia. In: Papadakis MA, McPhee SJ, Rabow MW. Current Medical Diagnosis and Treatment 2020. New York, NY: McGraw-Hill Education; 2020.
  13. Ball SG, Iqbal Z. Diagnosis and treatment of hyponatraemia. Best Pract Res Clin Endocrinol Metab 2016;30(2):161–173. DOI: 10.1016/j.beem.2015.12.001.
  14. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 2006;119(1):71.e1-8. DOI: 10.1016/j.amjmed.2005.09.026.
  15. Nguyen MK, Ornekian V, Butch AW, Kurtz I. A new method for determining plasma water content: application in pseudohyponatremia. Am J Physiol Renal Physiol 2007;292(5):F1652–F1656. DOI: 10.1152/ajprenal.00493.2006.
  16. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med 1999;106(4):399–403. DOI: 10.1016/s0002-9343(99)00055-8.
  17. Schrier RW. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol JASN 2006;17(7): 1820–1832. DOI: 10.1681/ASN.2006030240.
  18. Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med 2000;342(21): 1581–1589. DOI: 10.1056/NEJM200005253422107.
  19. Adrogué HJ, Madias NE. The challenge of hyponatremia. J Am Soc Nephrol: JASN 2012;23(7):1140–1148. DOI: 10.1681/ASN.2012020128.
  20. Tenny S, Thorell W. Cerebral Salt Wasting Syndrome, In:, StatPearls. Treasure Island (FL): StatPearls Publishing; 2020.
  21. Ashraf N, Locksley R, Arieff AI. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med 1981;70(6):1163–1168. DOI: 10.1016/0002-9343(81)90822-6.
  22. Spital A. Hyponatremia in adrenal insufficiency: review of pathogenetic mechanisms. South Med J 1982;75(5):581–585. DOI: 10.1097/00007611-198205000-00018.
  23. Biswas M, Davies JS. Hyponatraemia in clinical practice. Postgrad Med J 2007;83(980):373–378. DOI: 10.1136/pgmj.2006.056515.
  24. Frizelle FA, Colls BM. Hyponatremia and seizures after bowel preparation: report of three cases. Dis Colon Rectum 2005;48(2): 393–396. DOI: 10.1007/s10350-004-0778-6.
  25. Diederich S, Franzen N-F, Bähr V, Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol 2003;148(6):609–617. DOI: 10.1530/eje.0.1480609.
  26. Karp BI, Laureno R. Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia. Medicine (Baltimore) 1993;72(6):359–373. DOI: 10.1097/00005792-199311000-00001.
  27. Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 2007;120(11 Suppl. 1):S1–S21. DOI: 10.1016/j.amjmed.2007.09.001.
  28. Furst H, Hallows KR, Post J, Chen S, Kotzker W, Goldfarb S, et al. The urine/plasma electrolyte ratio: a predictive guide to water restriction. In: American Journal of the Medical Sciences. Lippincott Williams and Wilkins; 2000. 240–244. DOI: 10.1097/00000441-200004000- 00007.
  29. Decaux G, Schlesser M, Coffernils M, Prospert F, Namias B, Brimioulle S, et al. Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia. Clin Nephrol 1994;42(2):102–108.
  30. Musch W, Verfaillie L, Decaux G. Age-related increase in plasma urea level and decrease in fractional urea excretion: clinical application in the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol 2006;1(5):909–914. DOI: 10.2215/CJN. 00320106.
  31. Decaux G, Musch W, Penninckx R, Soupart A. Low plasma bicarbonate level in hyponatremia related to adrenocorticotropin deficiency. J Clin Endocrinol Metab 2003;88(11):5255–5257. DOI: 10.1210/jc.2003-030399.
  32. Sterns RH, Nigwekar SU, Hix JK. The treatment of hyponatremia. Semin Nephrol 2009;29(3):282–299. DOI: 10.1016/j.semnephrol.2009.03.002.
  33. Berl T. The Adrogue-Madias formula revisited. Clin J Am Soc Nephrol 2007;2(6):1098–1099. DOI: 10.2215/CJN.03300807.
  34. Ganguli A, Mascarenhas RC, Jamshed N, Tefera E, Veis JH. Hyponatremia: Incidence, risk factors, and consequences in the elderly in a home-based primary care program. Clin Nephrol 2015;84(2):75–85. DOI: 10.5414/CN108453.
  35. Agarwal SM, Agrawal A. A comparative study of the clinico-aetiological profile of hyponatremia at presentation with that developing in the hospital. Indian J Med Res 2011;134(7):118–122.
  36. Shapiro DS, Sonnenblick M, Galperin I, Melkonyan L, Munter G. Severe hyponatraemia in elderly hospitalized patients: prevalence, aetiology and outcome. Intern Med J 2010;40(8):574–580. DOI: 10.1111/j.1445-5994.2010.02217.x.
  37. Gill G, Huda B, Boyd A, Skagen K, Wile D, Watson I, et al. Characteristics and mortality of severe hyponatraemia - a hospital-based study. Clin Endocrinol (Oxf) 2006;65(2):246–249. DOI: 10.1111/j.1365-2265.2006.02583.x.
  38. Hoorn EJ, Lindemans J, Zietse R. Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant 2006;21(1):70–76. DOI: 10.1093/ndt/gfi082.
  39. Kutz A, Ebrahimi F, Sailer CO, Wagner U, Schuetz P, Mueller B, et al. Seasonality of hypoosmolar hyponatremia in medical inpatients–data from a nationwide cohort study. J Clin Endocrinol Metabol 2020;105(4):dgz320. DOI: 10.1210/clinem/dgz320.
  40. Annane D, Decaux G, Smith N. Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia. Am J Med Sci 2009;337(1):28–36. DOI: 10.1097/MAJ.0b013e31817b8148.
  41. Gerbes AL, Gülberg V, Ginès P, Decaux G, Gross P, Gandjini H, et al. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology 2003;124(4):933–939. DOI: 10.1053/gast.2003.50143.
  42. Peri A. Management of hyponatremia: causes, clinical aspects, differential diagnosis and treatment. Expert Rev Endocrinol Metabol 2019;14(1):13–21. DOI: 10.1080/17446651.2019.1556095.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.